Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHA:603168)

China · Delayed Price · Currency is CNY

5.07

-0.07 (-1.36%)

Jul 30, 2026, 3:00 PM CST

SHA:603168 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	459.57	462.78	483.96	644.97	549.54	629.76
Revenue Growth	2.62%	-4.38%	-24.96%	17.37%	-12.74%	81.59%
Gross Profit	186.16	195.11	231.29	356.85	315.97	397.18
Operating Income	-29.12	-31.96	-57.73	20.71	39.62	41.6
Net Income	-273.68	-238.72	-123.44	25.41	44.75	35.66
Earnings Per Share	-0.77	-0.64	-0.33	0.07	0.14	0.11
EPS Growth	-	-	-	-50.00%	27.27%	-

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Sale of Merchandise	312.77
Medical Service	126.6
Total	439.37

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	121.03	224.4	189.65	369.2	554.33	243.55
Total Debt	266.83	300.95	254.34	175.69	39.69	37.61
Net Cash (Debt)	-145.81	-76.55	-64.69	193.51	514.64	205.94
Net Cash Growth	-	-	-	-62.40%	149.90%	-54.92%
Net Cash Per Share	-0.41	-0.21	-0.17	0.53	1.61	0.64

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	26.49	44.93	25.67	41.49	115.72	100.78
Capital Expenditures	-107.25	-94.15	-128.11	-219.8	-148.69	-153.44
Free Cash Flow	-80.76	-49.22	-102.43	-178.3	-32.97	-52.66
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	40.51%	42.16%	47.79%	55.33%	57.50%	63.07%
Operating Margin	-6.34%	-6.91%	-11.93%	3.21%	7.21%	6.61%
Pretax Margin	-59.79%	-51.85%	-23.88%	5.13%	9.83%	7.76%
Profit Margin	-59.55%	-51.58%	-25.51%	3.94%	8.14%	5.66%
FCF Margin	-17.57%	-10.64%	-21.17%	-27.64%	-6.00%	-8.36%

Dividends

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	0.021	0.037
Dividend Per Share Growth	-43.24%	-
Dividend Yield	0.16%	0.41%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	200.12	75.92	85.77
Forward PE	-	39.75	39.75	39.75	39.75	39.75
PS Ratio	4.13	5.95	5.20	7.88	6.18	4.86